9 Potential Winners of Facebook’s Big Spend

The beleagured social-media giant is ramping up capex next year to reinvent itself and build its metaverse. Analyst’s pick the potential beneficiaries, including names like Arista Networks, Nvidia, Cisco, and Ciena. Read More...


Novavax Stock Offers ‘Another Attractive Entry Point,’ Says Analyst

Well folks, it finally happened. After a series of delays which culminated in a recent Politico article saying Novavax (NVAX) was unable to get its Covid-19 vaccine (NVX-CoV2373) manufacturing up to the standard required for filing with the regulators, the company at last submitted its EUA filing to the UK MHRA (Medicines and Healthcare products Regulatory Agency). “Importantly,” said B. Riley analyst Mayank Mamtani, “The filing with MHRA includes all modules required for regulatory review, incl

Read More